The yin and yang of itaconate metabolism and its impact on the tumor microenvironment

Curr Opin Biotechnol. 2023 Oct 6;84:102996. doi: 10.1016/j.copbio.2023.102996. Online ahead of print.ABSTRACTThe tumor microenvironment (TME) consists of a network of metabolically interconnected tumor and immune cell types. Macrophages influence the metabolic composition within the TME, which directly impacts the metabolic state and drug response of tumors. The accumulation of oncometabolites, such as succinate, fumarate, and 2-hydroxyglutarate, represents metabolic vulnerabilities in cancer that can be targeted therapeutically. Immunometabolites are emerging as metabolic regulators of the TME impacting immune cell functions and cancer cell growth. Here, we discuss recent discoveries on the potential impact of itaconate on the TME. We highlight how itaconate influences metabolic pathways relevant to immune responses and cancer cell proliferation. We also consider the therapeutic implications of manipulating itaconate metabolism as an immunotherapeutic strategy to constrain tumor growth.PMID:37806082 | DOI:10.1016/j.copbio.2023.102996
Source: Current Opinion in Biotechnology - Category: Biotechnology Authors: Source Type: research